Growth · Healthtech
410 Medical raises $12m in growth financing
Orlando Health Ventures leads an oversubscribed round backing commercial expansion and the next LifeFlow device.
Hospital investors back a broader rollout
Tampa General and an undisclosed strategic investor join the financing, alongside existing healthcare and venture backers. The July 14 announcement reports LifeFlow use across more than 500 hospitals and EMS agencies and nearly 80,000 patients treated.
The company plans to extend adoption to additional health systems while developing its next-generation infuser, targeted for launch in 2027. That timetable makes this round support for both the current commercial product and the next device.
Funding history
Growth · This round$12M